Trademark Attorney / Law Firm

Brent Burningham – Trademark Portfolio

Brent Burningham specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 4 of 5 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 2 other Nice Classification classes. Filing activity spans from 1992 to 2026. Currently, 3 trademarks are registered and 1 is pending.

5 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Brent Burningham's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademark applications has Brent Burningham filed?

Brent Burningham has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered, 1 pending, 1 abandoned.

What trademark classes does Brent Burningham specialize in?

Brent Burningham has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Brent Burningham been filing trademarks?

Brent Burningham's trademark filing history with the USPTO spans from 1992 to 2026, covering 34 years of trademark practice. During this period, Brent Burningham has handled 5 trademark applications.

What is Brent Burningham's trademark registration success rate?

Brent Burningham has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.